High-content functional screen to identify proteins that correct F508del-CFTR function

Molecular and Cellular Proteomics

Volumn 8, Issue 4, 2009, Pages 780-790

  Trzciñska Daneluti, Agata M ^a   Ly, Diane ^a   Huynh, Lise ^a   Jiang, Chong ^a   Fladd, Christopher ^a   Rotin, Daniela ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BORONIC ACID DERIVATIVE; BORTEZOMIB; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR DELTA F508; MUTANT PROTEIN; PROTEOME; PYRAZINE DERIVATIVE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL; ARTICLE; CELL LINE; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOBLOTTING; METABOLISM; METHODOLOGY; PROTEOMICS; REPRODUCIBILITY; TEMPERATURE;

ANIMALS; BORONIC ACIDS; CELL LINE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; MICROSCOPY, CONFOCAL; MUTANT PROTEINS; PROTEOME; PROTEOMICS; PYRAZINES; REPRODUCIBILITY OF RESULTS; TEMPERATURE;

EID: 65749105978     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M800268-MCP200     Document Type: Article

References (47)

1. Ratjen, F., and Doring, G. (2003) Cystic fibrosis. Lancet 361, 681-689
2. Riordan, J. R. (2008) CFTR function and prospects for therapy. Annu. Rev. Biochem. 77, 701-726
3. Kerem, B., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., and Tsui, L. C. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073-1080
4. Yang, Y., Devor, D. C., Engelhardt, J. F., Ernst, S. A., Strong, T. V., Collins, F. S., Cohn, J. A., Frizzell, R. A., and Wilson, J. M. (1993) Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. Hum. Mol. Genet. 2, 1253-1261
5. Yang, Y., Janich, S., Cohn, J. A., and Wilson, J. M. (1993) The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc. Natl. Acad. Sci. U. S. A. 90, 9480-9484
6. Zhang, F., Kartner, N., and Lukacs, G. L. (1998) Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat. Struct. Biol. 5, 180-183
7. Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., and Welsh, M. J. (1992) Processing of mutant cystic fibrosis transmem-brane conductance regulator is temperature-sensitive. Nature 358, 761-764
8. Sato, S., Ward, C. L., Krouse, M. E., Wine, J. J., and Kopito, R. R. (1996) Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J. Biol. Chem. 271, 635-638
9. Galietta, L. J., Springsteel, M. F., Eda, M., Niedzinski, E. J., By, K., Haddadin, M. J., Kurth, M. J., Nantz, M. H., and Verkman, A. S. (2001) Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquinolizinium lead compounds. J. Biol. Chem. 276, 19723-19728
10. Ma, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J., and Verkman, A. S. (2002) Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J. Clin. Investig. 110, 1651-1658
11. Ma, T., Vetrivel, L., Yang, H., Pedemonte, N., Zegarra-Moran, O., Galietta, L. J., and Verkman, A. S. (2002) High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening. J. Biol. Chem. 277, 37235-37241
12. Yang, H., Shelat, A. A., Guy, R. K., Gopinath, V. S., Ma, T., Du, K., Lukacs, G. L., Taddei, A., Folli, C., Pedemonte, N., Galietta, L., and Verkman, A. S. (2003) Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating. J. Biol. Chem. 278, 35079-35085
13. Pedemonte, N., Lukacs, G. L., Du, K., Caci, E., Zegarra-Moran, O., Galietta, L. J., and Verkman, A. S. (2005) Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J. Clin. Investig. 115, 2564-2571
14. Carlile, G. W., Robert, R., Zhang, D., Teske, K. A., Luo, Y., Hanrahan, J. W., and Thomas, D. Y. (2007) Correctors of protein trafficking defects identified by a novel high-throughput screening assay. Chembiochem 8, 1012-1020
15. Robert, R., Carlile, G. W., Pavel, C., Liu, N., Anjos, S. M., Liao, J., Luo, Y., Zhang, D., Thomas, D. Y., and Hanrahan, J. W. (2008) Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect. Mol. Pharmacol. 73, 478-489
16. Loo, T. W., Bartlett, M. C., and Clarke, D. M. (2005) Rescue of DeltaF508 and other misprocessed CFTR mutants by a novel quinazoline compound. Mol. Pharm. 2, 407-413
17. Van Goor, F., Straley, K. S., Cao, D., Gonzalez, J., Hadida, S., Hazlewood, A., Joubran, J., Knapp, T., Makings, L. R., Miller, M., et al. (2006) Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L1117-L1130
18. Galietta, L. J., Haggie, P. M., and Verkman, A. S. (2001) Green fluorescent protein-based halide indicators with improved chloride and iodide affinities. FEBS Lett. 499, 220-224
19. Yang, D., Buchholz, F., Huang, Z., Goga, A., Chen, C. Y., Brodsky, F. M., and Bishop, J. M. (2002) Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 99, 9942-9947
20. Caci, E., Caputo, A., Hinzpeter, A., Arous, N., Fanen, P., Sonawane, N. D., Verkman, A. S., Ravazzolo, R., Zegarra-Moran, O., and Galietta, L. J. (2008) Evidence for direct CFTR inhibition by CFTRinh-172 based on arginine 347 mutagenesis. Biochem. J. 413, 135-142
21. Lamesch, P., Li, N., Milstein, S., Fan, C., Hao, T., Szabo, G., Hu, Z., Venkatesan, K., Bethel, G., Martin, P., et al. (2007) hORFeome v3.1: a resource of human open reading frames representing over 10, 000 human genes. Genomics 89, 307-315
22. Bardag-Gorce, F., Vu, J., Nan, L., Riley, N., Li, J., and French, S. W. (2004) Proteasome inhibition induces cytokeratin accumulation in vivo. Exp. Mol. Pathol. 76, 83-89
23. Shringarpure, R., Catley, L., Bhole, D., Burger, R., Podar, K., Tai, Y. T., Kessler, B., Galardy, P., Ploegh, H., Tassone, P., et al. (2006) Gene expression analysis of B-lymphoma cells resistant and sensitive to bort-ezomib. Br. J. Haematol. 134, 145-156
24. Choo-Kang, L. R., and Zeitlin, P. L. (2001) Induction of HSP70 promotes DeltaF508 CFTR trafficking. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L58-L68
25. Wang, X., Venable, J., LaPointe, P., Hutt, D. M., Koulov, A. V., Coppinger, J., Gurkan, C., Kellner, W., Matteson, J., Plutner, H., et al. (2006) Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127, 803-815
26. Meacham, G. C., Lu, Z., King, S., Sorscher, E., Tousson, A., and Cyr, D. M. (1999) The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis. EMBO J. 18, 1492-1505
27. Amaral, M. D. (2004) CFTR and chaperones: processing and degradation. J. Mol. Neurosci. 23, 41-48
28. Shuai, K., and Liu, B. (2003) Regulation of JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 3, 900-911
29. Besancon, F., Przewlocki, G., Baro, I., Hongre, A. S., Escande, D., and Edelman, A. (1994) Interferon-gamma downregulates CFTR gene expression in epithelial cells. Am. J. Physiol. 267, 1398-1404
30. Kulka, M., Dery, R., Nahirney, D., Duszyk, M., and Befus, A. D. (2005) Differential regulation of cystic fibrosis transmembrane conductance regulator by interferon gamma in mast cells and epithelial cells. J. Pharmacol. Exp. Ther. 315, 563-570
31. Kelley, T. J., and Elmer, H. L. (2000) In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium. J. Clin. Investig. 106, 403-410
32. Kreiselmeier, N. E., Kraynack, N. C., Corey, D. A., and Kelley, T. J. (2003) Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 285, L1286-L1295
33. de Jonge, H. W., Dekkers, D. H., Tilly, B. C., and Lamers, J. M. (2002) Cyclic stretch and endothelin-1-mediated activation of chloride channels in cultured neonatal rat ventricular myocytes. Clin. Sci. (Lond.) 103, Suppl. 48, 148S-151S
34. Chalmers, G. W., Macleod, K. J., Sriram, S., Thomson, L. J., McSharry, C., Stack, B. H., and Thomson, N. C. (1999) Sputum endothelin-1 is increased in cystic fibrosis and chronic obstructive pulmonary disease. Eur. Respir. J. 13, 1288-1292
35. Norkina, O., Graf, R., Appenzeller, P., and De Lisle, R. C. (2006) Caerulein-induced acute pancreatitis in mice that constitutively overexpress Reg/PAP genes. BMC Gastroenterol. 6, 16-26
36. Sarles, J., Barthellemy, S., Ferec, C., Iovanna, J., Roussey, M., Farriaux, J. P., Toutain, A., Berthelot, J., Maurin, N., Codet, J. P., et al. (1999) Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis. Arch. Dis. Child Fetal Neonatal Ed. 80, F118-F122
37. Barthellemy, S., Maurin, N., Roussey, M., Ferec, C., Murolo, S., Berthezene, P., Iovanna, J. L., Dagorn, J. C., and Sarles, J. (2001) Evaluation of 47, 213 infants in neonatal screening for cystic fibrosis, using pancreati tis-associated protein and immunoreactive trypsinogen assays. Arch. Pediatr. 8, 275-281
38. Xu, Y., Clark, J. C., Aronow, B. J., Dey, C. R., Liu, C., Wooldridge, J. L., and Whitsett, J. A. (2003) Transcriptional adaptation to cystic fibrosis trans-membrane conductance regulator deficiency. J. Biol. Chem. 278, 7674-7682
39. Pedersen, S. K., Sloane, A. J., Prasad, S. S., Sebastian, L. T., Lindner, R. A., Hsu, M., Robinson, M., Bye, P. T., Weinberger, R. P., and Harry, J. L. (2005) An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: application to cystic fibrosis. Mol. Cell. Proteomics 4, 1052-1060
40. Macgregor, G., Gray, R. D., Hilliard, T. N., Imrie, M., Boyd, A. C., Alton, E. W., Bush, A., Davies, J. C., Innes, J. A., Porteous, D. J., and Greening, A. P. (2008) Biomarkers for cystic fibrosis lung disease: application of SELDI-TOF mass spectrometry to BAL fluid. J. Cyst. Fibros.
41. Yao, T., Song, L., Xu, W., DeMartino, G. N., Florens, L., Swanson, S. K., Washburn, M. P., Conaway, R. C., Conaway, J. W., and Cohen, R. E. (2006) Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1. Nat. Cell Biol. 8, 994-1002
42. Hamazaki, J., Iemura, S., Natsume, T., Yashiroda, H., Tanaka, K., and Murata, S. (2006) A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26 S proteasomes. EMBO J. 25, 4524-4536
43. Vij, N., Fang, S., and Zeitlin, P. L. (2006) Selective inhibition of endoplasmic reticulum-associated degradation rescues DeltaF508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications. J. Biol. Chem. 281, 17369-17378
44. Zhang, L. N., Karp, P., Gerard, C. J., Pastor, E., Laux, D., Munson, K., Yan, Z., Liu, X., Godwin, S., Thomas, C. P., Zabner, J., Shi, H., Caldwell, C. W., Peluso, R., Carter, B., and Engelhardt, J. F. (2004) Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway. Mol. Ther. 10, 990-1002
45. Johnson, L. G., Olsen, J. C., Sarkadi, B., Moore, K. L., Swanstrom, R., and Boucher, R. C. (1992) Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat. Genet. 2, 21-25
46. Thomas, S. R., Jaffe, A., Geddes, D. M., Hodson, M. E., and Alton, E. W. (1999) Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion. Lancet 353, 984-985
47. Fajac, I., Hubert, D., Bienvenu, T., Richaud-Thiriez, B., Matran, R., Kaplan, J. C., Dall'Ava-Santucci, J., and Dusser, D. J. (1998) Relationships between nasal potential difference and respiratory function in adults with cystic fibrosis. Eur. Respir. J. 12, 1295-1300